• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
Are we prescribing antibiotics wrong?

Are we prescribing antibiotics wrong?

The message has always been clear: make sure to finish your full course of antibiotics. Or else? Risk the development of antibiotic resistance - a...
Outsourcing Clinical Trials Outside of the US

Outsourcing Clinical Trials Outside of the US

Outsourcing clinical trials has been a subject of both controversy and relevance in the pharmaceutical community. It is an important part of drug...
Regulators And Standards Groups Take Steps To Address Emerging Technologies In Biopharma

Regulators And Standards Groups Take Steps To Address Emerging Technologies In Biopharma

Last year was a banner year for new drugs, with 46 new molecular entities approved by the FDA, compared to 22 in 2016. 2017 also saw the approval of...
Two-dimensional liquid chromatography with multiple heart-cutting

Two-dimensional liquid chromatography with multiple heart-cutting

Two-dimensional liquid chromatography (2D-LC) has obtained increasing focus over the past two decades. At LEO Pharma, we continuously evaluate new...
Understanding Pharmaceutical Logistics Validation in a Dynamic Environment

Understanding Pharmaceutical Logistics Validation in a Dynamic Environment

Applying validation standards to bio/pharmaceutical logistics, the science of transporting bio/analytical, clinical and manufactured product, is an...
Are we prescribing antibiotics wrong?
Are we prescribing antibiotics wrong?
Outsourcing Clinical Trials Outside of the US
Outsourcing Clinical Trials Outside of the US
Regulators And Standards Groups Take Steps To Address Emerging Technologies In Biopharma
Regulators And Standards Groups Take Steps To Address Emerging Technologies In Biopharma
Two-dimensional liquid chromatography with multiple heart-cutting
Two-dimensional liquid chromatography with multiple heart-cutting
Understanding Pharmaceutical Logistics Validation in a Dynamic Environment
Understanding Pharmaceutical Logistics Validation in a Dynamic Environment

Latest White Papers

  • Random

Latest News

  • Title
  • Most Views
  • Recently Added
  • Ordering
  • Random
Load More
Load More
cobas pure integrated solutions

Roche received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the cobas® ...

 Myositis Association’s

Florida, providing a clinical overview of dermatomyositis (DM) and the latest information on ...

Lunit SCOPE IO

A new phase II clinical trial validated the efficacy of Lunit's AI biomarker, Lunit SCOPE IO, in ...

Gladstone developed a biological device

If you want to track a person's activities for a day, you could call them up every ten minutes and ...

Load More
Load More
Load More

Latest Updates

Lifespin GmbH, based in Regensburg (Germany), with offices in Boston, Massachusetts, that it has installed additional Nuclear Magnetic Resonance (NMR) equipment which will double Lifespin’s annual ...

Lifespin GmbH, based in Regensburg (Germany), with offices in Boston, Massachusetts, that it has installed additional Nuclear Magnetic Resonance (NMR) equipment which will double Lifespin’s annual laboratory testing capacity

Lifespin will now be able to scan and create the corresponding ...

Single Pass, Inc. CEO, Bill Colone, the initiation of the clinical evaluation for the Kronos Electrocautery device designed to improve the safety of co-axial biopsy procedures.

The single-use, ...

Single Pass, Inc. CEO, Bill Colone, the initiation of the clinical evaluation for the Kronos Electrocautery device designed to improve the safety of co-axial biopsy procedures.

The single-use, disposable device uses battery current to heat the probe tip to cauterize the tissue damaged by the ...

NaNotics LLC, a biopharmaceutical company developing NaNots™, novel subtractive nanoparticles that treat disease by capturing and clearing pathogenic molecules from blood.

A research ...

NaNotics LLC, a biopharmaceutical company developing NaNots™, novel subtractive nanoparticles that treat disease by capturing and clearing pathogenic molecules from blood.

A research collaboration with Mass General Cancer Center, a program of Massachusetts General Hospital (MGH) in Boston, to ...

Fresenius Kabi, a global health care company that specializes in pharmaceuticals, medical technologies, and nutrition products for critical and chronic conditions.

That the United States (U.S.) ...

Fresenius Kabi, a global health care company that specializes in pharmaceuticals, medical technologies, and nutrition products for critical and chronic conditions.

That the United States (U.S.) Food and Drug Administration (FDA) has approved its biosimilar, Stimufend® (pegfilgrastim-fpgk), for ...

Novogene at the forefront of cutting-edge next-generation sequencing (NGS) services, has officially Falcon II, a superpowered robot scientist for autonomously intelligent NGS delivery.

Falcon, ...

Novogene at the forefront of cutting-edge next-generation sequencing (NGS) services, has officially Falcon II, a superpowered robot scientist for autonomously intelligent NGS delivery.

Falcon, the precursor of Falcon II, launched in March 2020, and is the first fully optimized, automated, and ...

QOL Medical, LLC, a ground-breaking, rare disease pharmaceutical company, that the United States (U.S.) Food & Drug Administration (FDA) approved Sucraid®.

single-use containers for patients ...

QOL Medical, LLC, a ground-breaking, rare disease pharmaceutical company, that the United States (U.S.) Food & Drug Administration (FDA) approved Sucraid®.

single-use containers for patients more than 33 lb (15 kg) with Congenital Sucrase-Isomaltase Deficiency (CSID).

Currently, Sucraid® ...